The role of short-term oxygen administration in the prevention of intimal hyperplasia

Charu Lata, Derrick Green, Jing Wan, Sabita Roy, Steven M. Santilli

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Intimal hyperplasia (IH) is the cause of most failed arteriovenous fistulas (AVFs), resulting in repeat procedures and leading to increased utilization of scarce health care resources. Our laboratory has previously demonstrated the role of supplemental oxygen in preventing IH and smooth muscle cell proliferation (SMCp) at an artery-to-graft anastomosis and at the deployment site of an intra-arterial stent. This study examines the effect of supplemental oxygen in preventing IH and SMCp in an AVF in a rabbit model. Methods: Ninety-six rabbits were randomized into four groups: group 1, control; group 2, no surgery with supplemental oxygen; group 3, AVF without supplemental oxygen; and group 4, AVF with supplemental oxygen. Rabbits receiving supplemental oxygen received 30% oxygen for up to 42 days. Specimens were collected in all groups at days 1, 3, 7, 21, 42, and 90. IH and SMCp were measured at the AVF site as well as in the artery and vein proximal and distal to the AVF. Results: IH was first noted at day 7 and significantly increased through day 90 at all locations in the nonoxygen-supplemented groups. No significant IH was noted in the oxygen-supplemented group at any location or any time point. SMCp was noted at day 3 through day 21 in the nonoxygen- supplemented group, whereas almost no SMCp was noted in the oxygen-supplemented group at any location or time point. Conclusions: Without oxygen supplementation, SMCp begins at day 3 and is no longer noted at day 21 after creation of an AVF, whereas IH begins by day 7 and increases at least through day 90 after creation of an AVF. Forty-two days of 30% supplemental oxygen inhibits IH and SCMp after creation of an AVF. These data suggest a role for the short-term administration of low-dose O2 to prevent both IH and SMCp after creation of an AVF that may prolong patency and function.

Original languageEnglish (US)
Pages (from-to)452-459
Number of pages8
JournalJournal of Vascular Surgery
Volume58
Issue number2
DOIs
StatePublished - Aug 1 2013
Externally publishedYes

Fingerprint

Tunica Intima
Arteriovenous Fistula
Hyperplasia
Oxygen
Smooth Muscle Myocytes
Cell Proliferation
Rabbits
Arteries
Health Resources
Stents
Veins

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

The role of short-term oxygen administration in the prevention of intimal hyperplasia. / Lata, Charu; Green, Derrick; Wan, Jing; Roy, Sabita; Santilli, Steven M.

In: Journal of Vascular Surgery, Vol. 58, No. 2, 01.08.2013, p. 452-459.

Research output: Contribution to journalArticle

Lata, Charu ; Green, Derrick ; Wan, Jing ; Roy, Sabita ; Santilli, Steven M. / The role of short-term oxygen administration in the prevention of intimal hyperplasia. In: Journal of Vascular Surgery. 2013 ; Vol. 58, No. 2. pp. 452-459.
@article{b20051ee585241dd855b0e560835a661,
title = "The role of short-term oxygen administration in the prevention of intimal hyperplasia",
abstract = "Objective: Intimal hyperplasia (IH) is the cause of most failed arteriovenous fistulas (AVFs), resulting in repeat procedures and leading to increased utilization of scarce health care resources. Our laboratory has previously demonstrated the role of supplemental oxygen in preventing IH and smooth muscle cell proliferation (SMCp) at an artery-to-graft anastomosis and at the deployment site of an intra-arterial stent. This study examines the effect of supplemental oxygen in preventing IH and SMCp in an AVF in a rabbit model. Methods: Ninety-six rabbits were randomized into four groups: group 1, control; group 2, no surgery with supplemental oxygen; group 3, AVF without supplemental oxygen; and group 4, AVF with supplemental oxygen. Rabbits receiving supplemental oxygen received 30{\%} oxygen for up to 42 days. Specimens were collected in all groups at days 1, 3, 7, 21, 42, and 90. IH and SMCp were measured at the AVF site as well as in the artery and vein proximal and distal to the AVF. Results: IH was first noted at day 7 and significantly increased through day 90 at all locations in the nonoxygen-supplemented groups. No significant IH was noted in the oxygen-supplemented group at any location or any time point. SMCp was noted at day 3 through day 21 in the nonoxygen- supplemented group, whereas almost no SMCp was noted in the oxygen-supplemented group at any location or time point. Conclusions: Without oxygen supplementation, SMCp begins at day 3 and is no longer noted at day 21 after creation of an AVF, whereas IH begins by day 7 and increases at least through day 90 after creation of an AVF. Forty-two days of 30{\%} supplemental oxygen inhibits IH and SCMp after creation of an AVF. These data suggest a role for the short-term administration of low-dose O2 to prevent both IH and SMCp after creation of an AVF that may prolong patency and function.",
author = "Charu Lata and Derrick Green and Jing Wan and Sabita Roy and Santilli, {Steven M.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.jvs.2012.11.041",
language = "English (US)",
volume = "58",
pages = "452--459",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - The role of short-term oxygen administration in the prevention of intimal hyperplasia

AU - Lata, Charu

AU - Green, Derrick

AU - Wan, Jing

AU - Roy, Sabita

AU - Santilli, Steven M.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Objective: Intimal hyperplasia (IH) is the cause of most failed arteriovenous fistulas (AVFs), resulting in repeat procedures and leading to increased utilization of scarce health care resources. Our laboratory has previously demonstrated the role of supplemental oxygen in preventing IH and smooth muscle cell proliferation (SMCp) at an artery-to-graft anastomosis and at the deployment site of an intra-arterial stent. This study examines the effect of supplemental oxygen in preventing IH and SMCp in an AVF in a rabbit model. Methods: Ninety-six rabbits were randomized into four groups: group 1, control; group 2, no surgery with supplemental oxygen; group 3, AVF without supplemental oxygen; and group 4, AVF with supplemental oxygen. Rabbits receiving supplemental oxygen received 30% oxygen for up to 42 days. Specimens were collected in all groups at days 1, 3, 7, 21, 42, and 90. IH and SMCp were measured at the AVF site as well as in the artery and vein proximal and distal to the AVF. Results: IH was first noted at day 7 and significantly increased through day 90 at all locations in the nonoxygen-supplemented groups. No significant IH was noted in the oxygen-supplemented group at any location or any time point. SMCp was noted at day 3 through day 21 in the nonoxygen- supplemented group, whereas almost no SMCp was noted in the oxygen-supplemented group at any location or time point. Conclusions: Without oxygen supplementation, SMCp begins at day 3 and is no longer noted at day 21 after creation of an AVF, whereas IH begins by day 7 and increases at least through day 90 after creation of an AVF. Forty-two days of 30% supplemental oxygen inhibits IH and SCMp after creation of an AVF. These data suggest a role for the short-term administration of low-dose O2 to prevent both IH and SMCp after creation of an AVF that may prolong patency and function.

AB - Objective: Intimal hyperplasia (IH) is the cause of most failed arteriovenous fistulas (AVFs), resulting in repeat procedures and leading to increased utilization of scarce health care resources. Our laboratory has previously demonstrated the role of supplemental oxygen in preventing IH and smooth muscle cell proliferation (SMCp) at an artery-to-graft anastomosis and at the deployment site of an intra-arterial stent. This study examines the effect of supplemental oxygen in preventing IH and SMCp in an AVF in a rabbit model. Methods: Ninety-six rabbits were randomized into four groups: group 1, control; group 2, no surgery with supplemental oxygen; group 3, AVF without supplemental oxygen; and group 4, AVF with supplemental oxygen. Rabbits receiving supplemental oxygen received 30% oxygen for up to 42 days. Specimens were collected in all groups at days 1, 3, 7, 21, 42, and 90. IH and SMCp were measured at the AVF site as well as in the artery and vein proximal and distal to the AVF. Results: IH was first noted at day 7 and significantly increased through day 90 at all locations in the nonoxygen-supplemented groups. No significant IH was noted in the oxygen-supplemented group at any location or any time point. SMCp was noted at day 3 through day 21 in the nonoxygen- supplemented group, whereas almost no SMCp was noted in the oxygen-supplemented group at any location or time point. Conclusions: Without oxygen supplementation, SMCp begins at day 3 and is no longer noted at day 21 after creation of an AVF, whereas IH begins by day 7 and increases at least through day 90 after creation of an AVF. Forty-two days of 30% supplemental oxygen inhibits IH and SCMp after creation of an AVF. These data suggest a role for the short-term administration of low-dose O2 to prevent both IH and SMCp after creation of an AVF that may prolong patency and function.

UR - http://www.scopus.com/inward/record.url?scp=84880836809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880836809&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2012.11.041

DO - 10.1016/j.jvs.2012.11.041

M3 - Article

C2 - 23380177

AN - SCOPUS:84880836809

VL - 58

SP - 452

EP - 459

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -